| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.44 | 8e-05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.41 | 5e-05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.36 | 0.0009 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.27 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.26 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |